Effects of Eslicarbazepine Acetate (BIA 2-093) on Cognition and Psychomotor Function
Clinical trial NCT02284828 · COMPLETED
Trial details
- NCT number
- NCT02284828
- Sponsor
- Bial - Portela C S.A.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2007-09-01
- Primary completion
- 2007-11-01
- Enrollment
- 26
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.